secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001006837-25-000134
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE's MediBeacon receives FDA approval for next-gen TGFR System
--------------------------------------------------------------------

- MediBeacon (44.7%-owned by VATE) gets FDA nod for TGFR System with reusable sensor.
- Reusable sensor lowers cost vs prior single-use version; designed for patient comfort.
- Initial sales at select US and China academic medical centers expected Q1 2026.
- TGFR System featured as lead article in Journal of the American Society of Nephrology August 2025.
- Transdermal GFR assessment does not require age, weight, sex, race, or ethnicity inputs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/0001006837-25-000134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/hchc-20251216.htm
  HTML page:      https://secwatch.observer/filing/0001006837-25-000134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer